Rosen Law Firm reminded purchasers of Hims & Hers Health, Inc. securities traded on the NYSE between August 4, 2025, and July 29, 2026, inclusive, that November 2, 2026, is the deadline to seek appointment as lead plaintiff in an already-filed securities class action. The complaint alleges Hims shared consumers’ health information with third-party advertising platforms and charged consumers for prescriptions almost immediately after intake forms were submitted, despite telling consumers they could consult a medical provider to find a treatment that was "right for them." It further alleges that the conduct exposed Hims to regulatory scrutiny and potential fees and penalties, making the company’s positive statements about its business, operations and prospects materially misleading or unsupported. No class has been certified. Investors may seek lead-plaintiff status, retain counsel of their choice, or remain absent class members without taking action, and participation in any potential recovery does not depend on serving as lead plaintiff. Rosen said investors may obtain information through its website, Phillip Kim, Esq., at 866-767-3653, or [email protected], with no out-of-pocket fees or costs under a contingency-fee arrangement.